Skip to content

Unani treatment for heavy menstrual bleeding

Effect of Sharbat Habbul Aas in Heavy Menstrual Bleeding- A pre and post interventional study without control

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052713
Enrollment
32
Registered
2023-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Sharbat Habbul Aas (Myrtus communis): Sharbat Habbul Aas will be prepared as per the standard method mentioned in classical Unani text and will be administered orally for 7 days for 3 c

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients in age group of 18-42 years with regular cycles (21-35 days) with MBL > 80 ml and DOB >7 days for 2 out of 3 consecutive cycles Patients with PBAC score >1001 Patients with thickened endometrium and adenomyosis Patients with uterine fibroid Patient with non-specific cause of HMB Patient with mild to moderate anemia with iron supplementation

Exclusion criteria

Exclusion criteria: HTN, DM & Thyroid dysfunction Bleeding disorders, severe anemia (Hb Surgical causes of HMB H/o hormonal contraceptives in last 3 months

Design outcomes

Primary

MeasureTime frame
Reduction in PBAC score and DOBTimepoint: 4 months

Secondary

MeasureTime frame
Improvement in Hb% and QOLTimepoint: 4 months

Countries

India

Contacts

Public ContactProf Ismath Shameem

National Institution of Unani Medicine

dr.ismaths@gmail.com9538274583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026